AbogenBio News and Activities
Presence
AbogenBio develops biotechnology medicines and vaccines based on RNA technology. Its main products and services include vaccine development, drug discovery, and manufacturing support for healthcare providers, research partners, and pharmaceutical companies.
AbogenBio products and services overview:
- RNA vaccines
- RNA therapeutics
- Drug discovery
- Manufacturing services
- Delivery systems
Revenue: ~$0 million
Employees: 500
Headquarters: Suzhou, China
AbogenBio is one of the...
Executives
View the org chart displaying its 10 main executives
Most searched biographies at AbogenBio
- Ying Bo, Chief Executive Officer
- Nancy Wang, Senior Director of Human Resources
- Yan Zhang, Chief Financial Officer
Create your alert
to follow the executive moves at AbogenBio.
Biotechnology
AbogenBio has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
- NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
- Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..
Popular contacts in Biotechnology
News
Press releases by AbogenBio
Social media about AbogenBio
- AbogenBio on Wikipedia, Google News & Yahoo Finance
- AbogenBio on LinkedIn, X (Twitter) & YouTube
